Community leads the way: the essential role of CBO-anchored community health worker partnerships in strengthening hydroxyurea uptake and sickle cell disease care
Open Access
- 15 January 2026
- journal article
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 3 (1)
Abstract
Objectives: Hydroxyurea (HU) is an evidence-based, disease-modifying therapy that reduces complications for individuals with sickle cell disease (SCD). Despite its benefits, HU uptake remains suboptimal, particularly in historically marginalized communities facing barriers such as healthcare mistrust, misinformation, and structural inequities. In 2020, NYC Health + Hospitals (H + H) launched a citywide initiative, funded by the US Office of Minority Health, to improve HU use by partnering with community-based organizations (CBOs) and community health workers (CHWs) to address these barriers. Methods: The initiative was evaluated through an independent, mixed-methods study conducted by the New York State Department of Health. This system-wide intervention reached over 300 providers, with 99 actively participating in the incentive program, and impacted approximately 400 pediatric patients annually, with outcomes assessed in a matched cohort of 730 Medicaid-enrolled patients. Our CBO’s intervention involved culturally grounded health education, peer support, and practical assistance with non-clinical needs. Evaluation methods included qualitative interviews with clinicians, CHWs, and program leaders, supplemented by quantitative analyses of healthcare utilization and pharmacy data from pre- (2019) and post-intervention (2022-2023) periods. Results: The CBO–hospital partnership was essential to the initiative’s success. The CBO provided trusted community infrastructure, within which CHWs delivered frontline education, navigation, and social support, addressed social determinants of health and strengthened trust between families and clinical teams. Statistically significant improvements were observed: HU fills increased from 57% to 79%, adherence improved from 33% to 40%, and patients seen by participating providers were significantly less likely to have emergency department visits after adjustment. Qualitative data confirmed that the CBO-anchored CHW model was a critical driver of these outcomes. Conclusion: Integrating trusted community organizations into clinical care models can overcome entrenched barriers, improve HU adherence, and advance health equity in SCD care.Keywords
Funding Information
- Office of Minority Health (OMH) of the U.S. Department of Health and Human Services
- OMH/OASH/HHS (MP-CPI-20-002)
- U.S. Government
This publication has 10 references indexed in Scilit:
- Improving Hydroxyurea Uptake in Children: Results from a Provider Incentive Program in a Large Metropolitan Health SystemJournal Of Health Care For The Poor and Underserved, 2025
- Eliminating Health Care Access and Quality Inequities in Sickle Cell Disease: Policy Lessons from the End Sepsis InitiativeJournal Of Health Care For The Poor and Underserved, 2024
- High hydroxyurea usage in sickle cell anemia regardless of patient demographicsPediatric Blood & Cancer, 2023
- Sickle cell disease—unity and patient-centred educationThe Lancet Haematology, 2023
- Barriers to hydroxyurea use from the perspectives of providers, individuals with sickle cell disease, and families: Report from a U.S. regional collaborativeFrontiers in Genetics, 2022
- Hydroxyurea Use for Sickle Cell Disease Among Medicaid-Enrolled ChildrenPediatrics, 2019
- Effect of Community Health Worker Support on Clinical Outcomes of Low-Income Patients Across Primary Care FacilitiesJAMA Internal Medicine, 2018
- Sickle cell diseaseThe Lancet, 2017
- Community Health Workers as Support for Sickle Cell CareAmerican Journal of Preventive Medicine, 2016
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995